Report overview
Antiviral drug resistance refers to decreased susceptibility towards a drug which occurs due to changes in viral genotypes. During instances of antiviral resistance, the drugs have either lost their effectiveness or have been diminished against the virus to be targeted. Antiviral drug resistance is a rising concern among the immune-compromised patients.
This report aims to provide a comprehensive presentation of the global market for Antiviral Drug Resistance, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Drug Resistance. This report contains market size and forecasts of Antiviral Drug Resistance in global, including the following market information:
Global Antiviral Drug Resistance Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Antiviral Drug Resistance market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Immunodiagnostics Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Antiviral Drug Resistance include AccuBioTech Co., Ltd., ACON Laboratories, Inc., Siemens AG, BioMerieux SA, Bio-Rad Laboratories, Inc., Danaher, Abbott, BD and F. Hoffmann-La Roche Ltd., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antiviral Drug Resistance companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antiviral Drug Resistance Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Antiviral Drug Resistance Market Segment Percentages, by Type, 2023 (%)
Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Sanger Sequencing
Other Technologies
Global Antiviral Drug Resistance Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Antiviral Drug Resistance Market Segment Percentages, by Application, 2023 (%)
Hospitals & Clinics
Pathology or Diagnostic Laboratories
Research Institutes
Others
Global Antiviral Drug Resistance Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Antiviral Drug Resistance Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antiviral Drug Resistance revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Antiviral Drug Resistance revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
AccuBioTech Co., Ltd.
ACON Laboratories, Inc.
Siemens AG
BioMerieux SA
Bio-Rad Laboratories, Inc.
Danaher
Abbott
BD
F. Hoffmann-La Roche Ltd.
Trinity Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antiviral Drug Resistance, market overview.
Chapter 2: Global Antiviral Drug Resistance market size in revenue.
Chapter 3: Detailed analysis of Antiviral Drug Resistance company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antiviral Drug Resistance in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
